Roche Accu-Check® FlexLink Insulin Recall Lawyer & Lawsuit

Tweet

Recall alert for diabetics: Insulin is now being recalled nationwide due to defective delivery systems that can result in the under-delivery of insulin. Life-threatening hyperglycemia can result if diabetics use these products.

Free Roche Accu-Check FlexLink Insulin Recall Case Evaluation: If you or a loved one has been injured by an insulin delivery system included in this recall, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.

What’s the problem?

February 25, 2011 – This week, Roche Insulin Delivery Systems announced the recall of its ACCU-CHEK FlexLink Plus infusion set because of the potential for under-delivery of insulin. Insufficient levels of insulin can lead to dangerously elevated blood glucose levels (hyperglycemia) in diabetics.

This recall applies to the ACCU-CHECK FlexLink Plus set that was launched in November 2010, and appears to be due to a kinked cannula when inserting the infusion set. Roche is advising all customers to stop using the infusion set and to contact their physicians or caregivers immediately.

Hyperglycemia Symptoms

Early signs of hyperglycemia in diabetes include (but are not limited to):

• headaches
• difficulty concentrating
• blurred vision
• frequent urination
• fatigue (weak, tired feeling)
• weight loss
• blood glucose more than 180 mg/dL
• vaginal & skin infections
• nerve damage
• stomach & intestinal problems

Do I have an Insulin Recall Lawsuit?

The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Roche Accu-Check FlexLink insulin delivery system recall lawsuits. We are handling individual litigation nationwide and currently accepting new hyperglycemia cases in all 50 states.